VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,717,000 | -38.6% | 533,332 | 0.0% | 2.34% | -47.5% |
| Q4 2021 | $22,331,000 | -3.8% | 533,332 | 0.0% | 4.45% | -5.6% |
| Q3 2021 | $23,211,000 | -8.0% | 533,332 | 0.0% | 4.71% | +21.1% |
| Q2 2021 | $25,216,000 | -7.8% | 533,332 | 0.0% | 3.89% | -24.7% |
| Q1 2021 | $27,344,000 | +64.1% | 533,332 | -14.3% | 5.16% | +110.2% |
| Q4 2020 | $16,663,000 | -22.0% | 622,221 | 0.0% | 2.46% | -25.7% |
| Q3 2020 | $21,361,000 | -16.2% | 622,221 | 0.0% | 3.30% | -27.2% |
| Q2 2020 | $25,492,000 | – | 622,221 | – | 4.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |